COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Response to PARP Inhibitor Predicted by the RAD51 Assay (REPAIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03044795
Recruitment Status : Withdrawn (The study never started)
First Posted : February 7, 2017
Last Update Posted : July 5, 2019
Dutch Cancer Society
Information provided by (Responsible Party):
J.A. Gietema, University Medical Center Groningen

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2020